COMMUNIQUÉS West-GlobeNewswire

Jasper Therapeutics Announces Briquilimab Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress
03/06/2025
REDWOOD CITY, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting [...]
Philips launches intelligent 3D imaging in Europe to empower faster stroke care, helping physicians save time, brain, and lives
03/06/2025
Demonstrated at LINNC Paris 2025, the company’s latest release of SmartCT delivers fast, intelligent 3D imaging in the Angio suite — helping physicians act with greater speed and confidence during a range of critical [...]
IMUNON Announces Data Presented at ASCO Reinforces Unprecedented Overall Survival in Ovarian Cancer Phase 2 Study
03/06/2025
Consistent OS Efficacy Benefit Across Multiple Treatment Subgroups Demonstrates IMNN-001’s Ability to Recruit a Powerful Anti-Cancer Immune Response Results, presented simultaneously in oral presentation at ASCO 2025 [...]
Communiqué de presse : ASCO : de nouvelles données sur le Sarclisa appuient l’administration sous-cutanée avec un injecteur sur le corps
03/06/2025
ASCO : de nouvelles données sur le Sarclisa appuient l’administration sous-cutanée avec un injecteur sur le corps De nouvelles données provenant de deux études cliniques ont démontré que le Sarclisa administré par voie [...]
Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector
03/06/2025
ASCO: new Sarclisa data support subcutaneous administration with on-body injector New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector [...]
Rose Hill Life Sciences Executes Exclusive License Agreement with Johns Hopkins University for Restoration of Motor Function Post-Neurological Injury Using Psychedelics
03/06/2025
BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Rose Hill Life Sciences , a global leader in the research and intellectual property of premium psilocybin products, has signed an agreement with Johns Hopkins University to [...]
QHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare Efficiency
03/06/2025
Recent publications highlight the efficacy of QHSLab's digital assessments in primary care, offering benefits for providers, patients, and practice revenue. WEST PALM BEACH, FL, June 03, 2025 (GLOBE NEWSWIRE) -- QHSLab [...]
Safety Shot, Inc. Developing Next-Generation Nootropic and Sleep Solutions by leveraging Core 'Feel Better Fast' Expertise
03/06/2025
Company to Expand Patented Wellness Approach into High-Growth Cognitive and Restorative Sleep Markets, Emphasizing Scientific Rigor and Unique Formulations SCOTTSDALE, AZ, June 03, 2025 (GLOBE NEWSWIRE) -- Safety Shot, [...]
Nanox to Participate in Sidoti Small Cap Conference
03/06/2025
Management to present on Wednesday, June 11 at 1:45 PM ET PETACH TIKVA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“ Nanox ” or the “ Company ”), an innovative medical imaging [...]
NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary
03/06/2025
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
03/06/2025
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission (“ [...]
Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals
03/06/2025
25,000 U.S. adults per year claim reimbursement for medical costs associated with babesiosis v. CDC estimates of 2,000 A full 45 percent of persistent babesiosis cases include chronic fatigue Healthcare providers [...]
L’AVENIR DE LA PRODUCTION ALIMENTAIRE EST FAIT AU CANADA : Le Défi Cultiver l’innovation d’ici offre une subvention de 20 M$ dans le cadre de sa phase de mise à l’échelle pour soutenir la production alimentaire nationale
03/06/2025
TORONTO, 03 juin 2025 (GLOBE NEWSWIRE) -- Il est plus essentiel que jamais d’assurer au Canada un approvisionnement alimentaire sécuritaire et durable. Poursuivant son engagement de longue date envers l’amélioration du [...]
THE FUTURE OF FOOD IS MADE IN CANADA: The Homegrown Innovation Challenge Launches $20M Scaling Phase Grant to Support Domestic Food Production
03/06/2025
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- It has never been more important for Canada to have a secure and sustainable supply of food. Building on its longstanding commitment to improving the well-being of Canadians, [...]
BON Announces Share Repurchase Program for up to US$1.0 Million
03/06/2025
XI’AN, China, June 03, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today [...]
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
03/06/2025
Patent covers estimation of measures of heart function using an ECG, which are critical in the diagnosis and early detection of heart disease Southlake, TX, June 03, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: [...]
H1 Acquires Veda to Solve Healthcare’s Provider Data Challenge and Power Better Care
03/06/2025
Acquisition equips health plans with next-generation provider data management, enabling improved access to care and better health outcomes NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- H1 , on a mission to connect the [...]
BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates
03/06/2025
Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically distinct, orally active, and highly potent small molecule APJ agonists [...]
Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
03/06/2025
Screening test provides prenatal risk assessment for common genetic conditions in one blood draw without the need for paternal testing Early access via large-scale clinical study to establish the validity and utility of [...]

Pages